Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
5
Bearish filings
40
Named actors
12
Disclosed $ (bull / bear)
$47K / $7.2M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-04-29 | Chief Medical Officer Baumal Caroline | gifted | — | SEC ↗ |
| 2026-04-17 | Chief Financial Officer Sullivan Timothy Eugene | gifted | — | SEC ↗ |
| 2026-04-06 | Activist (13D) BIOGEN INC. | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-03-11 | Chief Executive Officer Francois Cedric | gifted | — | SEC ↗ |
| 2026-02-17 | 5%+ holder (13G) RTW INVESTMENTS, LP | disclosed a passive stake (13G) | — | SEC ↗ |
20 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-02-11 | Chief Business & Strat Officer DeLong Mark Jeffrey | sold | $8K | SEC ↗ |
| 2026-02-06 | 5%+ holder (13G) BlackRock, Inc. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-03 | Chief Executive Officer Francois Cedric | exercised options & held the shares | $33K | — |
| 2026-01-22 | General Counsel Watson David O. | sold | $171K | SEC ↗ |
| 2026-01-22 | Chief Financial Officer Sullivan Timothy Eugene | sold | $224K | SEC ↗ |
| 2026-01-22 | Chief Technical Officer Nicholson Nur | sold | $168K | SEC ↗ |
| 2026-01-22 | Chief Executive Officer Francois Cedric | sold | $592K | SEC ↗ |
| 2026-01-22 | Chief Scientific Officer Deschatelets Pascal | sold | $129K | SEC ↗ |
| 2026-01-22 | Chief Business & Strat Officer DeLong Mark Jeffrey | sold | $73K | SEC ↗ |
| 2026-01-22 | VP/Chief Accounting Officer Chopas James George | sold | $45K | SEC ↗ |
| 2026-01-22 | Chief Medical Officer Baumal Caroline | sold | $61K | SEC ↗ |
| 2026-01-20 | General Counsel Watson David O. | sold | $49K | SEC ↗ |
| 2026-01-20 | Chief Financial Officer Sullivan Timothy Eugene | sold | $57K | SEC ↗ |
| 2026-01-20 | Chief Technical Officer Nicholson Nur | sold | $44K | SEC ↗ |
| 2026-01-20 | Chief Executive Officer Francois Cedric | sold | $162K | SEC ↗ |
| 2026-01-20 | Chief Scientific Officer Deschatelets Pascal | sold | $18K | SEC ↗ |
| 2026-01-20 | Chief Business & Strat Officer DeLong Mark Jeffrey | sold | $26K | SEC ↗ |
| 2026-01-20 | VP/Chief Accounting Officer Chopas James George | sold | $14K | SEC ↗ |
| 2026-01-20 | Chief Medical Officer Baumal Caroline | sold | $37K | SEC ↗ |
| 2026-01-13 | General Counsel Watson David O. | sold | $128K | SEC ↗ |